Viewing Study NCT02540174



Ignite Creation Date: 2024-05-06 @ 7:29 AM
Last Modification Date: 2024-10-26 @ 11:48 AM
Study NCT ID: NCT02540174
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2015-09-01

Brief Title: Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer Interest of an Addiction Treatment
Sponsor: Centre Oscar Lambret
Organization: Centre Oscar Lambret

Study Overview

Official Title: Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer Interest of Integrating the Addiction Treatment to the Initial Cancer Treatment Program
Status: COMPLETED
Status Verified Date: 2019-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ALTAKRA-1405
Brief Summary: This is a multicenter interventional randomized study among patients with a first lung or head neck cancer who are still active smokers alcohol misusersThe study will aim to compare the systematic implementation of an addiction treatment program initiated at hospital and integrated to the initial cancer treatment program Arm A versus the as-usual procedure which consists in recommendations to follow an addiction treatment program Arm B
Detailed Description: Study proposal at the first medical consultation for therapeutic management of a first upper aerodigestive tract cancer or lung cancer
Selection criteria validation
Collection of an informed consent
Randomization

Arm A Experimental arm Addiction consultation to the overall cancer treatment

Arm B standard of care

The completion of questionnaires the measurement of exhaled carbone monoxide rate using a CO tester for all patients and the integrated addiction treatment among patients randomized in Arm A will not interfere with the medical treatment of cancer

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None